Alcohol Use and Depression: Public Health and Clinical Implications
DOI:
https://doi.org/10.12970/2310-8231.2014.02.03.4Keywords:
Depression, Alcohol Treatment, Co-morbidity, Epidemiology.Abstract
Alcohol is used on a national level as a social relaxant. Yet, misuse of alcohol can lead to considerably harms. In clinical psychiatry, the presence of comorbid alcohol abuse and depression are commonly encountered. This presents a challenging scenario for clinicians in terms of diagnostic conundrums, prognostic issues and treatment paradigms. This article reviews findings of key studies in the subject and offers practical suggestions to workers in the field. It also highlights the need for governments and public health agencies to focus on this important and highly prevalent problem.
References
Australian Government Department of Health. National alcohol Strategy 2006- 2011 Canberra: Commonwealth of Australia; 2006 [cited 4 November 2014]. Available from: http://www.alcohol.gov.au/internet/alcohol/publishing. nsf/Content/nas-06-09).
Ministerial Committee on Drug Strategy. National Drug Strategy 2010-2015. A framework for action on alcohol, tobacco and other drugs. Canberra: Department of Health and Ageing; 2011 [20 February 2014]. Available from: http://www.nationaldrugstrategy.gov.au/internet/drugstrategy/publishing.nsf/Content/DB4076D49F13309FCA257854007BAF30/$File/nds2015.pdf
Room R, Babor T, Rehm J. Alcohol and public health. The Lancet 2005; 365(9458): 519-30. http://dx.doi.org/10.1016/S0140-6736(05)17870-2
Sayal K, Heron J, Golding J, Emond A. Prenatal Alcohol Exposure and Gender Differences in Childhood Mental Health Problems: A Longitudinal Population-Based Study. Pediatrics 2007; 119(2): e426-e34. http://dx.doi.org/10.1542/peds.2006-1840
Mukherjee RAS, Hollins S, Abou-Saleh MT, Turk J. Low level alcohol consumption and the fetus 2005 2005-02-17 22: 59: 01. 375-6 p.
National Institute on Alcohol Abuse and Alcoholism. US Department of Health and Human services: 10th Special report to the US Congress on Alcohol and Health. Bethesda, Maryland: National Institutes of Health, 2000.
World Health Organisation. Global Status Report on Alcohol and Health. Geneva: World Health Organisation, 2011.
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition: American Psychiatric Publishing; 2013 May 2013.
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington DC: American Psychiatric Association; 2000.
Samet S, Nunes EV, Hasin D. Diagnosing comorbidity: concepts, criteria, and methods. Acta Neuropsychiatr 2004; 16(1): 9-18. http://dx.doi.org/10.1111/j.1601-5215.2004.0062.x
First M, Gibbon M, Spitzer R, Williams J. User’s Guide for the Structured Clinical Interview for DSM-IV-TR Axis I Disorders: SCID-I, Research Version. New York, New York State Psychiatric Institute, Biometric Research Department 2001.
Bucholz KK, Cadoret R, Cloninger CR, et al. A New, Semistructured Psychiatric Interview for Use in Genetic-Linkage Studies - a Report on the Reliability of the SSGA. J Stud Alcohol 1994; 55(2): 149-58.
Hasin DS, Trautman KD, Miele GM, Samet S, Smith M, Endicott J. Psychiatric research interview for substance and mental disorders (PRISM): Reliability for substance abusers. Am J Psychiat 1996; 153(9): 1195-201.
Swendsen JD, Merikangas KR. The comorbidity of depression and substance use disorders. Clin Psychol Rev 2000; 20(2): 173-89. http://dx.doi.org/10.1016/S0272-7358(99)00026-4
Maier W, Merikangas K. Co-occurrence and cotransmission of affective disorders and alcoholism in families. Brit J Psychiat 1996; 168: 93-100.
Kessler RC, Nelson CB, McGonagle KA, Edlund MJ, Frank RG, Leaf PJ. The epidemiology of co-occurring addictive and mental disorders: Implications for prevention and service utilization. Am J Orthopsychiat 1996; 66(1): 17-31. http://dx.doi.org/10.1037/h0080151
Regier DA, Farmer ME, Rae DS, et al. Comorbidity of Mental-Disorders with Alcohol and Other Drug-Abuse - Results from the Epidemiologic Catchment-Area (Eca) Study. Jama-J Am Med Assoc 1990; 264(19): 2511-8. http://dx.doi.org/10.1001/jama.1990.03450190043026
Almeida OP, Hankey GJ, Yeap BB, Golledge J, Flicker L. The triangular association of ADH1B genetic polymorphism, alcohol consumption and the risk of depression in older men. Mol Psychiatry 2014; 19(9): 995-1000. http://dx.doi.org/10.1038/mp.2013.117
Hasin DS, Grant DF. Major depression in 6050 former drinkers - Association with past alcohol dependence. Arch Gen Psychiat 2002; 59(9): 794-800. http://dx.doi.org/10.1001/archpsyc.59.9.794
Boschloo L, Vogelzangs N, van den Brink W, et al. Alcohol use disorders and the course of depressive and anxiety disorders. Brit J Psychiat 2012; 200(6): 476-84. http://dx.doi.org/10.1192/bjp.bp.111.097550
Boschloo L, Vogelzangs N, Smit JH, et al. Comorbidity and risk indicators for alcohol use disorders among persons with anxiety and/or depressive disorders Findings from the Netherlands Study of Depression and Anxiety (NESDA). J Affect Disorders 2011; 131(1-3): 233-42. http://dx.doi.org/10.1016/j.jad.2010.12.014
Hasin D, Liu XH, Nunes E, McCloud S, Samet S, Endicott J. Effects of major depression on remission and relapse of substance dependence. Arch Gen Psychiat 2002; 59(4): 375-80. http://dx.doi.org/10.1001/archpsyc.59.4.375
Grant BF, Harford TC. Comorbidity between DSM IV Alcohol-Use Disorders and Major Depression - Results of a National Survey. Drug Alcohol Depen 1995; 39(3): 197-206. http://dx.doi.org/10.1016/0376-8716(95)01160-4
Grant BF, Hasin DS. Suicidal ideation among the United States drinking population: Results from the National Longitudinal Alcohol Epidemiologic Survey. J Stud Alcohol 1999; 60(3): 422-9.
Shand F, Gates J, Fawcett J, Mattick R. Guidelines for the treatment of alcohol problems. National Drug and Alcohol Research Centre Canberra: Commonwealth Department of Health and Ageing; 2003 [20 February 2014]. Available from: http://www.alcohol.gov.au/internet/alcohol/publishing.nsf/Content/2C3FC9166082567DCA257260007F81F8/$File/alcprobguide.pdf
Schuckit MA, Tipp JE, Bergman M, Reich W, Hesselbrock VM, Smith TL. Comparison of induced and independent major depressive disorders in 2,945 alcoholics. Am J Psychiat 1997; 154(7): 948-57.
Finney JW, Hahn AC, Moos RH. The effectiveness of inpatient and outpatient treatment for alcohol abuse: The need to focus on mediators and moderators of setting effects. Addiction 1996; 91(12): 1773-96. http://dx.doi.org/10.1111/j.1360-0443.1996.tb03801.x
Anton RF, O'Malley SS, Ciraulo DA, et al. Combined pharmacotherapies and behavioral interventions for alcohol dependence - The COMBINE study: A randomized controlled trial. Jama-J Am Med Assoc 2006; 295(17): 2003-17. http://dx.doi.org/10.1001/jama.295.17.2003
Rösner S, Hackl-Herrwerth A, Leucht S, Vecchi S, Srisurapanont M, Soyka M. Opioid antagonists for alcohol dependence. Cochrane Database Syst Rev 2010; 12.
Mason BJ. Acamprosate in the treatment of alcohol dependence. Expert Opin Pharmaco 2005; 6(12): 2103-15. http://dx.doi.org/10.1517/14656566.6.12.2103
Morley KC, Teesson M, Reid SC, et al. Naltrexone versus acamprosate in the treatment of alcohol dependence: a multi-centre, randomized, double-blind, placebo-controlled trial. Addiction 2006; 101(10): 1451-62. http://dx.doi.org/10.1111/j.1360-0443.2006.01555.x
Carmen B, Angeles M, Ana M, Maria AJ. Efficacy and safety of naltrexone and acamprosate in the treatment of alcohol dependence: a systematic review. Addiction 2004; 99(7): 811-28. http://dx.doi.org/10.1111/j.1360-0443.2004.00763.x
Proude E, Lopatko O, Lintzeris N, Haber P. The Treatment of Alcohol Problems: A review of the evidence 2009 [Accessed 20 February 2014]. Available from: http://www.health.gov.au/ internet/alcohol/publishing.nsf/Content/877AC32A7ADD8AEECA2576C00007B5C7/$File/evid.pdf
Johnson BA. Medication Treatment of Different Types of Alcoholism. Am J Psychiat 2010; 167(6): 630-9. http://dx.doi.org/10.1176/appi.ajp.2010.08101500
Graham K, Massak A. Alcohol consumption and the use of antidepressants. Can Med Assoc J 2007; 176(5): 633-7. http://dx.doi.org/10.1503/cmaj.060446
Naranjo CA, Knoke DM. The role of selective serotonin reuptake inhibitors, in reducing alcohol consumption. J Clin Psychiat 2001; 62: 18-25.
Kranzler HR, Burleson JA, Brown J, Babor TF. Fluoxetine treatment seems to reduce the beneficial effects of cognitive-behavioral therapy in type B alcoholics. Alcohol Clin Exp Res 1996; 20(9): 1534-41. http://dx.doi.org/10.1111/j.1530-0277.1996.tb01696.x
Dundon W, Lynch KG, Pettinati HM, Lipkin C. Treatment outcomes in type A and B alcohol dependence 6 months after serotonergic pharmacotherapy. Alcohol Clin Exp Res 2004; 28(7): 1065-73. http://dx.doi.org/10.1097/01.ALC.0000130974.50563.04
Nunes EV, Levin FR. Treatment of depression in patients with alcohol or other drug dependence - A meta-analysis. Jama-Journal of the American Medical Association 2004; 291(15): 1887-96. http://dx.doi.org/10.1001/jama.291.15.1887
Pettinati HM, Oslin DW, Kampman KM, et al. A Double-Blind, Placebo-Controlled Trial Combining Sertraline and Naltrexone for Treating Co-Occurring Depression and Alcohol Dependence. Am J Psychiat 2010; 167(6): 668-75. http://dx.doi.org/10.1176/appi.ajp.2009.08060852
Vaillant GE. Alcoholics Anonymous: cult or cure? Aust Nz J Psychiat 2005; 39(6): 431-6. http://dx.doi.org/10.1080/j.1440-1614.2005.01600.x
Babor TF, et al. Comments on Project MATCH: matching alcohol treatments to client heterogeneity. Addiction 1999; 94(1): 31-69. http://dx.doi.org/10.1080/09652149934152
Miller WR, Leckman AL, Delaney HD, Tinkcom M. Long-Term Follow-up of Behavioral Self-Control Training. J Stud Alcohol 1992; 53(3): 249-61.
Klimas J, Field CA, Cullen W, et al. Psychosocial interventions to reduce alcohol consumption in concurrent problem alcohol and illicit drug users. Cochrane Db Syst Rev 2012(11).
Luty J. What works in alcohol use disorders? Advances in Psychiatric Treatment 2006; 12(1): 13-22. http://dx.doi.org/10.1192/apt.12.1.13
